Capacity planning under clinical trials uncertainty in continuous pharmaceutical manufacturing, 1: Mathematical framework

Industrial and Engineering Chemistry Research

Volumn 51, Issue 42, 2012, Pages 13692-13702

  Sundaramoorthy, Arul ^a   Evans, James M B ^a   Barton, Paul I ^a  

^a Massachusetts Institute of Technology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; CAPACITY PLANNING; CLINICAL TRIAL; DEVELOPMENT STAGES; EXPONENTIAL INCREASE; MATHEMATICAL FRAMEWORKS; MIXED-INTEGER LINEAR PROGRAMMING; MULTI-PERIOD; PHARMACEUTICAL MANUFACTURING; PROBLEM SIZE; PRODUCTION CAPACITY; SOLUTION METHODS;

AVAILABILITY; DRUG PRODUCTS; MANUFACTURE;

EXPERIMENTS;

EID: 84867758775     PISSN: 08885885     EISSN: 15205045     Source Type: Journal    
DOI: 10.1021/ie300324h     Document Type: Article

References (29)

1. Shah, N. Pharmaceutical supply chains: key issues and strategies for optimization Comput. Chem. Eng. 2004, 28, 929-941
2. Suresh, P.; Basu, P. K. Improving pharmaceutical product development and manufacturing: Impact on cost of drug development and cost of goods sold of pharmaceuticals J. Pharm. Innov. 2008, 3, 175-187
3. Stonebraker, J. S. How Bayer makes decision to develop new drugs Interfaces 2002, 32, 77-90
4. Beard, C.; Easingwood, C. New product launch: Marketing action and launch tactics for high-technology products Ind. Market. Manage. 1996, 25, 87-103
5. Grabowski, H. G.; Vernon, J. M. Effective patent life in pharmaceuticals Int. J. Technol. Manage. 2000, 19, 98-120
6. Schaber, S. D.; Georgiorgis, D. I.; Ramachandran, R.; Evans, J. M. B.; Barton, P. I.; Trout, B. L. Economic analysis of integrated and batch pharmaceutical manufacturing: A case study Ind. Eng. Chem. Res. 2011, 50, 10083-10092
7. Schmidt, C. W.; Grossmann, I. E. Optimization models for the scheduling of testing tasks in new product development Ind. Eng. Chem. Res. 1996, 35, 3498-3510
8. Jain, V.; Grossmann, I. E. Resource-constrained scheduling of tests in new product development Ind. Eng. Chem. Res. 1999, 38, 3013-3026
9. Blau, G.; Mehta, B.; Bose, S.; Pekny, J.; Sinclair, G.; Keunker, K.; Bunch, P. Risk management in the development of new products in highly regulated industries Comput. Chem. Eng. 2000, 24, 1005-1011
10. Subramanian, D.; Pekny, J. F.; Reklaitis, G. V. A simulation-optimization framework for research and development pipeline management AIChE J. 2001, 47, 2226-2242
11. Subramanian, D.; Pekny, J. F.; Reklaitis, G. V.; Blau, G. E. Simulation-optimization framework for stochastic optimization of R&D pipeline management AIChE J. 2003, 49, 96-112
12. Choi, J.; Realff, M. J.; Lee, J. H. Dynamic programming in a heuristically confined state space: A stochastic resource-constrained project scheduling application Comput. Chem. Eng. 2004, 28, 1039-1058
13. Colvin, M.; Maravelias, C. T. A stochastic programming approach for clinical trial planning in new drug development Comput. Chem. Eng. 2008, 32, 2626-2642
14. Colvin, M.; Maravelias, C. T. Scheduling of testing tasks and resource planning in new product development using stochastic programming Comput. Chem. Eng. 2009, 33, 964-976
15. Rotstein, G. E.; Papageorgiou, L. G.; Shah, N.; Murphy, D. C.; Mustafa, R. A product portfolio approach in the pharmaceutical industry Comput. Chem. Eng. 1999, 23, 883-886
16. Papageorgiou, G. E.; Rotstein, G. E.; Shah, N. Strategic supply chain optimization for the pharmaceutical industries Ind. Eng. Chem. Res. 2001, 40, 275-286
17. Gatica, G.; Papageorgiou, L. G.; Shah, N. Capacity planning under uncertainty for the pharmaceutical industry Trans. Inst. Chem. Eng. 2003, 81, 665-678
18. Maravelias, C. T.; Grossmann, I. E. Simultaneous planning for new product development and batch manufacturing facilities Ind. Eng. Chem. Res. 2001, 40, 6147-6164
19. Bagajewicz, M. On the use of net present value in investment capacity planning models Ind. Eng. Chem. Res. 2008, 47, 9413-9416
20. Rogers, M. J.; Gupta, A.; Maranas, C. D. Real options based analysis of optimal pharmaceutical research and development portfolios Ind. Eng. Chem. Res. 2002, 41, 6607-6620
21. Gupta, A.; Maranas, C. D. Real-options-based planning strategies under uncertainty Ind. Eng. Chem. Res. 2004, 43, 3870-3878
22. Rogers, M. J.; Maranas, C. D.; Ding, M. Valuation and design of pharmaceutical R&D licensing deals AIChE J. 2005, 51, 198-209
23. Hood, S. J.; Bermon, S.; Barahona, F. Capacity planning under demand uncertainty for semiconductor manufacturing IEEE Trans. Semicond. Manuf. 2003, 16, 273-280
24. Ahmed, S.; Sahinidis, N. V. An approximation scheme for stochastic integer programs arising in capacity expansion Oper. Res. 2003, 51, 461-471
25. Sahinidis, N. V. Optimization under uncertainty: State-of-the-art and opportunities Comput. Chem. Eng. 2004, 28, 971-983
26. Sundaramoorthy, A.; Karimi, I. A. Planning in pharmaceutical supply chains with outsourcing and new product introductions Ind. Eng. Chem. Res. 2004, 43, 8293-8306
27. Balasubramanian, J.; Grossmann, I. E. Approximation to multistage stochastic optimization in multiperiod batch plant scheduling under demand uncertainty Ind. Eng. Chem. Res. 2004, 43, 3695-3713
28. Sand, G.; Engell, S. Modeling and solving real-time scheduling problems by stochastic integer programming Comput. Chem. Eng. 2004, 28, 1087-1103
29. Sethi, S.; Sorger, G. A theory of rolling horizon decision making Annals Oper. Res. 1991, 29, 387-416